Realizing the Potential of the CB2 Receptor as a Therapeutic Target for AntiInflammatory Treatments
Time: 1:30 pm
day: Day Two
Details:
- Profiling CB2R’s role in the endocannabinoid system, and understanding the mechanism of action and how this translates to a clinical benefit
- Analyzing recent scientific advancements, including rationalising CB2 receptor structure-function relationships, AI approaches, and enhance ligand design
- Understanding how biased signalling and binding kinetics will improve tailored therapies
